Annabel Maruani
3
Documents
Identifiants chercheurs
- annabel-maruani
- ResearcherId : L-9017-2015
- IdRef : 088646270
- 0000-0003-3734-810X
- ResearcherId : http://www.researcherid.com/rid/L-9017-2015
Présentation
Publications
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
Management of tinea capitis in children following the withdrawal of griseofulvin from the French market: A fast-track algorithm proposed by the Center of Evidence of the French Society of DermatologyAnnales de Dermatologie et de Vénéréologie, In press, ⟨10.1016/j.annder.2022.07.001⟩
Article dans une revue
hal-03837146v1
|
Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of DermatologyBritish Journal of Dermatology, 2021, 185 (3), pp.658-660. ⟨10.1111/bjd.20415⟩
Article dans une revue
hal-03342687v1
|
|
Biological treatments for paediatric psoriasis (BiPe): A retrospective observational study on biological drug survival in daily practice in childhood psoriasisJournal of the European Academy of Dermatology and Venereology, 2019, 15 (1), pp.e1006646. ⟨10.1111/jdv.15579⟩
Article dans une revue
hal-02095496v1
|